Nivaan Care, a pioneer in the single-specialty interventional pain management sector, has raised $7 million (approximately ₹58 crore) in a Series A funding round. The investment was led by Sorin Investments, with strong participation from existing backers W Health Ventures, Endiya Partners, and Rebright Partners.
This milestone follows a successful $4.25 million seed round in February 2025, bringing the startup’s total capital raised to over $12 million. The fresh infusion will be used to aggressively expand Nivaan’s clinic footprint into new major metros like Bengaluru, enhance its digital and clinical infrastructure, and scale its non-surgical intervention programs.
Bridging the “Middle Layer” of Chronic Pain Care
Founded in 2023 by Nivesh Khandelwal and Vishwas Singh, Nivaan Care addresses a critical gap in the Indian healthcare system. For the estimated 270 million Indians suffering from chronic pain, treatment options often oscillate between temporary relief (basic physiotherapy/medication) and high-stakes invasive surgery.
Nivaan’s “middle layer” model focuses on interventional pain management—using advanced, minimally invasive daycare procedures to treat the root cause of pain.
A Multidisciplinary Care Model:
-
Interventional Pain Specialists: Lead diagnosis and advanced daycare procedures.
-
Physiotherapy & Rehab: Specialized movement therapy to restore long-term mobility.
-
Counseling & Nutrition: Addressing the psychological impact of chronic pain and reducing systemic inflammation through diet.
-
Care Coordinators: Personalized patient navigation throughout the recovery journey.
Proven Impact and Future Trajectory
Nivaan has quickly demonstrated the scalability of specialized pain clinics in the Indian market. The chain currently operates across Delhi-NCR, Mumbai, Jaipur, and Lucknow.
Key Growth Metrics:
-
Consultations: 40,000+ patients served since inception.
-
Procedures: 5,000+ minimally invasive interventions (including Radiofrequency Ablation and PRP therapy).
-
Clinical Excellence: 90% of patients have successfully avoided major surgeries through Nivaan’s protocols.
-
Network Target: Expansion from 15 existing centers to a goal of 60–75 clinics over the next four years.
“Chronic pain is a young specialty in India. While the US has over 4,000 interventional pain clinics, India has fewer than 200. We are building the infrastructure to bridge this gap at scale,” said Nivesh Khandelwal, Co-founder & CEO.
Investor Confidence
Mandar Dandekar, Partner at Sorin Investments, noted the structural difficulty of scaling pain management within traditional multi-specialty hospitals. “Nivaan’s full-stack approach allows for a level of personalization and clinical focus that is rare in this space. We believe they are positioned to become the national leader in integrated pain management.”
By: Vanshika Tayal
